Description
GP TNE 100 is an injectable water based steroid. It is pure testosterone and has no ester attached, and thus no ester calculated in the weight. Where 100 mg of a testosterone ester equals 100 mg minus the weight of the ester, 100 mg of TNE contains an actual 100 mg of the steroid. Very potent and very powerful. Although it is a rather crude compound, it is without a doubt very, very effective.
Testosterone is the most common anabolic hormone that there is and is also considered the most basic. Due to this, bodybuilders often consider it the base steroid to most all cycles. Testosterone is both anabolic and androgenic in nature. Users of GP TNE 100 will notice a dramatic gain in muscle size and strength, as well as an overall sense of well being and increases libido and sex drive.
Testosterone aromatizes very easily and therefore estrogen buildup and side effects can become an issue for users sensitive to these problems or those choosing to use a high dose of GP TNE. Therefore, when using Testosterone, bodybuilders often choose in incorporate an anti-estrogen such as Anastrozole, Proviron, Tamoxifen to help keep estrogen related side effects to a minimum. Extremely sensitive users, or users using very high doses (800-1200mg) might find that stronger anti-estrogens such as Letrozole or Exemestane are more suitable. Androgenic side effects such as oily skin are also possible while taking Testosterone.
Bodybuilders looking to bulk up, often stack GP TNE with other steroids such as GP Deca 250 and/or GP Bold 200, along with an oral compound such as GP Methan or GP Oxy. Those Bodybuilders looking to use testosterone during cutting phase, might wish to stack it with compounds such as GP Trens, along with an oral like GP Stan or GP Oxan.
The male bodybuilder’s dosage of GP TNE would typically be in 400-1200mg per week range and cycle duration would be from 8-20 weeks, depending of course on the goals of the athlete. Women typically see desirable results from doses of 50-100mg per week.
Reviews
There are no reviews yet.